Support Alert

Company led recall: Topotecan Medac 1mg/ml concentrate for solution for infusion

18 Sep 2015

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led recall for specified batches of Topotecan Medac 1mg/ml concentrate for solution for infusion by Medac GmbH.

The affected batches are being recalled because their sterility can no longer be guaranteed.

Further details of the alert, the affected batches and action to take are available on the MHRA website.

 
Loading...